Vaccine Market Report 2022

Vaccine Market Report 2022

Market At-A-Glance
In 2020, the global vaccine market was valued at $35.9 billion. Fueled by the pandemic, the prevalence of other diseases, and research and development the market is expected to more than double to $83.5 billion by 2027.

The U.S. alone is projected to reach $30 billion by 2027.
Routine Vaccinations Continued To Lag In 2021. Pandemic-driven declines in routine vaccines persisted in 2021. Compared to 2019, the steepest declines occurred in commercially insured adults. Adolescent rates temporarily increased when schools reopened and related activities began, but fell again afterward. From December 2020 to July 2021, people may have missed
approximately 11.1 million doses of recommended vaccines.

U.S. Influenza Vaccine Market Estimated To Reach $7.0 Billion By 2028
The U.S. influenza vaccine market was estimated at $3.8 billion in 2021 and is expected to surpass $7.0 billion by 2028. As of February 25, 2022, 174.9 million doses of flu vaccine were distributed in the U.S. during the 2021–2022 flu season. The 2021–2022 flu season doses are expected to fall short of the previous season’s total of 193.8 million. The global influenza vaccine market is expected to rebound from the pandemic-era decline.

First COVID-19 Vaccine Approved, With More In The Pipeline
On August 23, 2021, Pfizer-BioNTech’s COVID-19 became the first COVID-19 vaccine to receive full Food and Drug Administration (FDA) approval and the first mRNA vaccine for any illness. Moderna’s COVID-19 vaccine followed on January 31, 2022 when it received full FDA approval. As of February 18, 2022, there are 339 COVID-19 vaccine candidates in development worldwide.

Increased funding, resources, and scientific interest, as well as increased manufacturing capacity and research investments by COVID-19 mRNA vaccine makers, is fueling the market for other mRNA vaccines for a wide range
of diseases.

Global Market For FDA-Approved COVID-19 Vaccines To Reach $51 Billion In 2022
Globally, sales of the two FDA-approved COVID-19 vaccines are expected to reach $51 billion, slightly less than the 2021 total of $54 billion. In 2021, Pfizer broke the record for best-selling vaccine by exceeding $36 billion in annual sales. As of February 21, 2022, 10.6 billion doses of all COVID-19 vaccines have been administered around the world. 213.95 million people in the U.S. have received a complete initial protocol.

U.S. Pediatric Vaccine Market Expected To Reach $6.64 Billion By 2027
The U.S. pediatric vaccine market was valued at $3.13 billion in 2021. The Centers for Disease Control and Prevention (CDC) increased the number of recommended childhood vaccines over the past decade, and the market is expected to reach $6.64 billion by 2027. Growth is expected despite the pandemic continuing to suppress routine childhood vaccination rates.

Executive Summary
Vaccine Market Overview
Vaccines Become Major Contributor To Pharmacy Revenue
Pharmacy Technicians Nationwide Now Authorized To Vaccinate
Insurance Or Government Programs Cover Most Recommended Vaccines
Influenza Vaccine Market Expected To Rebound From Pandemic Dip
More Adults Receive Flu Vaccinations At Pharmacies Than Doctors’ Offices
Pandemic Continues To Suppress Flu Vaccination, Including In High-Risk Groups
Universal Flu Vaccine Candidate Could Negate Annual Shots
First Cell-Based Flu Vaccine Offers Better Match To Circulating Strains
COVID-19 Vaccine Market Remains Strong
First COVID-19 Vaccines Approved, More In Development
2021 COVID-19 mRNA Success Fuels Nucleic Acid Vaccines For Other Diseases
COVID-19 Vaccines Increase In Price
COVID-19 Vaccine Setting Shifts Away From Nontraditional Megasites
Workplace Vaccine Mandates Remain Controversial
CDC Research Points To Need For Four Or More COVID-19 Doses
COVID-19 Vaccine Split Widens On Rural Vs. Urban And Narrows On Race
Prefilled Syringes May Be On The Way For COVID-19 Vaccines
COVID-19 Vaccine Authorized For Children Under Five
U.S. Pediatric Vaccine Market Projected To Reach $6.64 Billion By 2027
First Six-In-One Combination Childhood Vaccine Hits The Market
Dengue And COVID-19 Vaccines Now Recommended For Some Children
HPV Vaccine Hesitancy Remains High
2-Dose HPV Vaccination Completion Tied To Wellness Visit Volume
CDC Makes Several Updates To Adult Immunization Schedule
Expanded Shingles Vaccine Recommendation May Be Coming

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings